Yahoo
NYSE - Delayed Quote USD

Bio-Rad Laboratories, Inc. (BIO)

372.18 -12.22 (-3.18%)
At close: October 30 at 4:00:02 PM EDT
372.18 0.00 (0.00%)
After hours: October 30 at 4:00:59 PM EDT
Trade BIO on Coinbase
Chart Range Bar
Loading chart for BIO
  • Previous Close 384.40
  • Open 381.09
  • Bid 365.11 x 8000
  • Ask 379.31 x 4000
  • Day's Range 368.45 - 381.29
  • 52 Week Range 236.73 - 396.23
  • Volume 183,084
  • Avg. Volume 255,337
  • Market Cap (intraday) 9.951B
  • Beta (5Y Monthly) 1.07
  • PE Ratio (TTM) 47.17
  • EPS (TTM) 7.89
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 335.00
  • Morningstar Rating Rating available with Stock Picks access

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

www.bio-rad.com

7,450

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BIO
22.84%
S&P 500 (^GSPC)
10.73%

1-Year Return

BIO
22.18%
S&P 500 (^GSPC)
11.11%

3-Year Return

BIO
38.17%
S&P 500 (^GSPC)
81.91%

5-Year Return

BIO
53.17%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share (Normalized)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 651M
Earnings --
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
200M
400M
600M
0.0%

Analyst Insights

View More

Analyst Price Targets

280.00 Low
335.00 Average
372.18 Current
390.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/7/2026
Analyst RBC Capital
Rating Action Maintains
Rating Outperform
Price Action Raises
Price Target 370 -> 390

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.59%

  • Return on Assets (ttm)

    1.66%

  • Return on Equity (ttm)

    3.11%

  • Revenue (ttm)

    2.59B

  • Net Income Avi to Common (ttm)

    222.4M

  • Diluted EPS (ttm)

    7.89

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.62B

  • Total Debt/Equity (mrq)

    19.10%

  • Levered Free Cash Flow (ttm)

    283.19M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: